Peptide record

TPDB03669

Antibacterial Anticancer Hemolysis Toxicity standard
11 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB03669
Antibacterial Anticancer Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 11-aa standard-residue multi-activity (Antibacterial, Anticancer, Hemolysis, and other sources) peptide sequence curated from AntiBP3, Peptipedia, HemoPI, and other sources, with an available 3D structural model.
Sequence
LKLFKKILKYL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C72H123N15O13
ARNDCEQGHMPSTWV
LK
1406.86
10.64
4
0
7
+4
-0.48
0.509
177.27
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
1490
1.06
1
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
1
I
4
L
4
K
0
M
1
F
0
P
0
S
0
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 4 K: 4 M: 0 F: 1 P: 0 S: 0 T: 0 W: 0 Y: 1 V: 0
Chemical Descriptors
11 reviewed residue count
C72H123N15O13 sequence-only estimate (linear, free termini)
1406.86 sequence-only estimate (linear, free termini)
10.64 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
-0.48 sequence-only estimate (linear, free termini)
0.509 sequence-only estimate (linear, free termini)
Evidence Records 6 records
Evidence 1 Activity

Activity

MIC
Antibacterial
5.0-7.5 µM

Target

v. syringae

Source & Reference

NA

Other

active against plant pathogenic bacterial strains P. syringae pv. syringae (MIC 5.0-7.5 uM), X. axonopodis pv. vesicatoria (MIC 2.5-5.0 uM), and E. amylovora (MIC 5.0-7.5 uM).
Evidence 2 Activity

Activity

MIC
Antibacterial
2.5-5.0 µM

Target

v. vesicatoria

Source & Reference

NA

Other

nt pathogenic bacterial strains P. syringae pv. syringae (MIC 5.0-7.5 uM), X. axonopodis pv. vesicatoria (MIC 2.5-5.0 uM), and E. amylovora (MIC 5.0-7.5 uM).
Evidence 3 Activity

Activity

MIC
Antibacterial
5.0-7.5 µM

Target

E. amylovora

Source & Reference

NA

Other

ringae pv. syringae (MIC 5.0-7.5 uM), X. axonopodis pv. vesicatoria (MIC 2.5-5.0 uM), and E. amylovora (MIC 5.0-7.5 uM).
Evidence 4 Activity

Activity

(91±6.2)% Hemolysis
Toxicity
150 µM
Hemolytic Cytotoxic
(91±6.2)% Hemolysis | 150 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Evidence 5 Activity

Activity

IC50
Toxicity
39.0±8.5 µM
Cytotoxic
IC50 | 39.0±8.5 | µM | target cell: Mouse fibroblasts NIH 3T3

Target

Mouse fibroblasts NIH 3T3

Source & Reference

NA
DBAASP
Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties. | Org Biomol Chem | 2014
Evidence 6 Hemolysis

Source & Reference

HemoPI PD_Hemolysis
PD_Hemolysis